Skip to main content

Benzodiazepine Dependence

Avoidance and Withdrawal

Summary

Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.

This is a preview of subscription content, access via your institution.

References

  • Ashton CH, Rawlins MD, Tyrer SP. A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. British Journal of Psychiatry 157: 232–238, 1990

    PubMed  CAS  Article  Google Scholar 

  • Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction 82: 665–671, 1987

    PubMed  CAS  Article  Google Scholar 

  • Barnes GE. The alcoholic personality: a review of the literature. Journal of Studies on Alcohol 40: 571–634, 1979

    PubMed  CAS  Google Scholar 

  • Beaumont G. The use of benzodiazepines in general practice. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 141–152, John Wiley & Sons, Chichester, 1990

    Google Scholar 

  • Brandon S. Clinical use of benzodiazepines in anxiety and panic disorders. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 111–139, John Wiley & Sons, Chichester, 1990

    Google Scholar 

  • Busto U, Sellers E, Naranjo CA, Cappell H, Sanchez-Craig M, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854–859, 1986

    PubMed  CAS  Article  Google Scholar 

  • Butler G, Cullington A, Hibbert G, Klines I, Gelder M. Anxiety management for persistent generalised anxiety. British Journal of Psychiatry 151: 535–542, 1987

    PubMed  CAS  Article  Google Scholar 

  • Cormack MA, Owens RG, Dewey ME. The effect of minimal interventions by general practitioners on long-term benzodiazepine use. Journal of the Royal College of General Practitioners 39: 408–411, 1989

    PubMed  CAS  Google Scholar 

  • Cowen PJ, Nutt DJ. Abstinence symptoms after withdrawal of tranquilising drugs: is there a common neurochemical mechanism? Lancet 2: 360–362, 1982

    PubMed  CAS  Article  Google Scholar 

  • Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. American Journal of Psychiatry 141: 845–852, 1984

    Google Scholar 

  • Greenblatt DJ, Shader RI, Divoll M, Harmatz BA. Benzodiazepines: a summary of pharmacokinetic properties. British Journal of Clinical Pharmacology 11: 115–165, 1981

    Article  Google Scholar 

  • Holton A, Riley P, Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. Journal of Affective Disorders 24: 245–252, 1992

    PubMed  CAS  Article  Google Scholar 

  • King MB, Gabe J, Williams P, Rodrigo EK. Long-term use of benzodiazepines: the views of patients. British Journal of General Practice 40: 194–196, 1990

    PubMed  CAS  Google Scholar 

  • Lader M. History of benzodiazepine dependence. Journal of Substance Abuse Treatment 8: 53–59, 1991

    PubMed  CAS  Article  Google Scholar 

  • Lader M, Beaumont G, Bond A, Butler G, Cobb J, et al. Guidelines for the management of patients with generalised anxiety. Psychiatric Bulletin 16: 560–565, 1992

    Article  Google Scholar 

  • Little HJ, Nutt DJ, Taylor SC. Bi-directional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor complex. Brain Research Reviews 19: 371, 1987

    CAS  Google Scholar 

  • Marks J. The benzodiazepines: use, overuse, misuse, abuse, MTP Press, Lancaster, 1978

    Google Scholar 

  • Miller NS, Gold MS. Benzodiazepines: a major problem. Introduction. Journal of Substance Abuse Treatment 8: 3–7, 1991

    PubMed  CAS  Article  Google Scholar 

  • Munby M, Johnstone DW. Agoraphobia: the long-term followup of behavioural treatment. British Journal of Psychiatry 137: 418–427, 1980

    PubMed  CAS  Article  Google Scholar 

  • Murphy SM, Owen RT, Tyrer PJ. Withdrawal symptoms after six weeks treatment with diazepam. Lancet 1: 1389, 1984

    Article  Google Scholar 

  • Murphy SM, Tyrer P. The essence of benzodiazepine dependence. In Lader (Ed.) The psychopharmacology of addiction, pp. 157–167, Oxford University Press, London, 1988

    Google Scholar 

  • Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry 158: 511–516, 1991

    PubMed  CAS  Article  Google Scholar 

  • Nutt DJ. Benzodiazepine dependence: New insights into basic research. In Hindmarch et al. (Eds) Benzodiazepines: current concepts, pp. 19–41, John Wiley & Sons, Chichester, 1990

    Google Scholar 

  • Onyett SR. The benzodiazepine withdrawal syndrome and its management. Journal of the Royal College of General Practioners, 39: 160–163, 1989

    CAS  Google Scholar 

  • Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283: 643–645, 1981

    PubMed  CAS  Article  Google Scholar 

  • Power KG, Jerrom DWA, Simpson RJ, Mitchell M. Controlled study of withdrawal symptoms and rebound anxiety after six weeks course of diazepam for generalised anxiety. British Medical Journal 290: 1246–1248, 1985

    PubMed  CAS  Article  Google Scholar 

  • Priest RG, Montgomery SA. Benzodiazepines and dependence: a College statement. Bulletin of the Royal College of Psychiatrists 12: 107–109, 1988

    Article  Google Scholar 

  • Rickels K, Case WG, Schweizer E, Garcia-Espana F, Fridman R. Benzodiazepine dependence: management of discontinuation. Psychopharmocology Bulletin 26: 63–68, 1989

    Google Scholar 

  • Schweizer E, Clary C, Dever AI, Mandos LA. The use of low dose midazolam to treat panic disorder: a pilot study. Journal of Clinical Psychiatry 53: 19–22, 1992

    PubMed  CAS  Google Scholar 

  • Seivewright N, Dougal W. Withdrawal symptoms from high dose benzodiazepines in polydrug users. Drug and Alcohol Dependence 32: 15–23, 1993

    PubMed  CAS  Article  Google Scholar 

  • Tesar GE. High potency benzodiazepine for short-term treatment of panic disorder: the US experience. Journal of Clinical Psychiatry 51: 4–10, 1990

    PubMed  Google Scholar 

  • Tyrer P. Dependence on benzodiazepines. British Journal of Psychiatry 137: 576–577, 1980

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P. Neurosis divisible?. Lancet 1: 685–688, 1985

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P. How to stop taking tranquillisers, Sheldon Press, London, 1986

    Google Scholar 

  • Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquillizers. Pharmacology and Therapeutics 36: 173–188, 1988

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P. Current problems with the benzodiazepines. In Wheatley (Ed.) The anxiolytic jungle: where next?, pp. 23–36, John Wiley, Chichester, 1990

    Google Scholar 

  • Tyrer P. The nocebo effect: poorly known but getting stronger. In Dukes & Aronson (Eds) Side effects of drugs annual 15, pp. xix–xxv, Elsevier, Amsterdam, 1991a

    Google Scholar 

  • Tyrer P. Qui devient dependant des benzodiazepines? In Venisse JL (Ed.) Les nouvelles addictions, pp. 142–147, Masson, Paris, 1991b

    Google Scholar 

  • Tyrer P. Pharmacological differences between benzodiazepines. In Hallstrom (Ed.) Benzodiazepine dependence, Oxford University Press, London, 1993a

    Google Scholar 

  • Tyrer P. Withdrawal from hypnotic drugs. British Medical Journal 305: 706–708, 1993b

    Article  Google Scholar 

  • Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1: 1402–1406, 1983

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P, Murphy S, Oates G, Kingdon D. Psychological treatment for benzodiazepine dependence. Lancet 1: 1042–1043, 1986

    Google Scholar 

  • Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionnaire. Journal of Affective Disorders 19: 53–61, 1990

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1: 520–522, 1981

    PubMed  CAS  Article  Google Scholar 

  • Tyrer P, Sievewright N. Identification and management of benzodiazepine dependence. Postgraduate Medical Journal 60: 41–46, 1984

    PubMed  Google Scholar 

  • Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatrica Scandinavica 85: 201–206, 1992

    PubMed  CAS  Article  Google Scholar 

  • Winokur A, Rickels K, Greenblatt PJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long-term low dosage administration of diazepam. Archives of General Psychiatry 37: 101–105, 1980

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Marriott, S., Tyrer, P. Benzodiazepine Dependence. Drug-Safety 9, 93–103 (1993). https://doi.org/10.2165/00002018-199309020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199309020-00003

Keywords

  • Personality Disorder
  • Withdrawal Symptom
  • Panic Disorder
  • Buspirone
  • Withdrawal Syndrome